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Serotonin is involved in updating responses to changing environmental circumstances. Optimising behaviour to maximise reward
and minimise punishment may require shifting strategies upon encountering new situations. Likewise, autonomic responses to
threats are critical for survival yet must be modified as danger shifts from one source to another. Whilst numerous psychiatric
disorders are characterised by behavioural and autonomic inflexibility, few studies have examined the contribution of serotonin in
humans. We modelled both processes, respectively, in two independent experiments (N= 97). Experiment 1 assessed instrumental
(stimulus-response-outcome) reversal learning whereby individuals learned through trial and error which action was most optimal
for obtaining reward or avoiding punishment initially, and the contingencies subsequently reversed serially. Experiment 2
examined Pavlovian (stimulus-outcome) reversal learning assessed by the skin conductance response: one innately threatening
stimulus predicted receipt of an uncomfortable electric shock and another did not; these contingencies swapped in a reversal
phase. Upon depleting the serotonin precursor tryptophan—in a double-blind randomised placebo-controlled design—healthy
volunteers showed impairments in updating both actions and autonomic responses to reflect changing contingencies. Reversal
deficits in each domain, furthermore, were correlated with the extent of tryptophan depletion. Initial Pavlovian conditioning,
moreover, which involved innately threatening stimuli, was potentiated by depletion. These results translate findings in
experimental animals to humans and have implications for the neurochemical basis of cognitive inflexibility.
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INTRODUCTION
Serotonin (5-HT; 5-hydroxytryptamine) is classically involved in
responding to negative events, is increasingly recognised to be
engaged in reward learning, and is important for adapting
previously learned responses to reflect new environmental
circumstances [1–10]. Whilst a unified framework for serotonin
function remains elusive, considering how serotonin influences
fundamental Pavlovian (stimulus-outcome) and instrumental
(stimulus-response-outcome; operant) learning processes has the
potential to make such an objective more tractable. Here, we
studied healthy human volunteers to examine the effects of
lowering serotonin synthesis on cognitive flexibility assessed by
instrumental and Pavlovian reversal learning.
Reversal learning paradigms, whereby an initial contingency is
learned and subsequently reverses, have revealed both Pavlovian
and instrumental reversal learning deficits in obsessive-
compulsive disorder (OCD), a prototypical disorder of cognitive
inflexibility [11, 12]. Pavlovian reversal deficits have also been
observed in post-traumatic stress disorder (PTSD) [13].
Instrumental reversal deficits, meanwhile, have been documented
in schizophrenia [14], gambling disorder [15], and alcohol [16],
methamphetamine, and cocaine use disorders [17]. Non-reversal
aberrations in Pavlovian threat and safety learning have also been
reported in OCD [18, 19], schizophrenia [20, 21], PTSD [22, 23], and
other anxiety disorders [22, 24, 25].
Serotonergic dysfunction, at the same time, has been docu-
mented across diagnostic categories [26–33]. A recent meta-
analysis, for example, showed decreased bioavailability of
tryptophan, serotonin’s precursor, as well as a shift in the
metabolism of tryptophan away from the serotonin biosynthesis
pathway in major depressive disorder, bipolar disorder, and
schizophrenia [30]. Moreover, post-mortem assessment of indivi-
duals with stimulant use disorder revealed decreased serotonin
concentration [34] and serotonin transporter (SERT) density [35] in
the orbitofrontal cortex (OFC). In OCD, reduced SERT in the OFC
has been reported [36]. There is additionally an array of evidence
from single-photon emission computed tomography (SPECT) and
positron emission tomography (PET) of decreased SERT in various
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other brain regions in OCD, including in drug- naïve individuals,
with some findings correlating with OCD symptom severity
[28, 37–41]. In PTSD and panic disorder, several studies suggest
an increased sensitivity of the 5-HT2C receptor as determined
through pharmacological challenge [33, 42, 43]. Dysfunction of the
5-HT1A receptor, assessed by PET, has additionally been reported
across PTSD, panic disorder, and social anxiety disorder [44–47].
Therefore, it is not surprising that drugs thought to boost
serotonin transmission when given chronically—selective seroto-
nin reuptake inhibitors (SSRIs)—are first line treatments for OCD
[48], PTSD [49], and depression [50]. Schizophrenia is treated with
drugs that modulate serotonin in addition to dopamine, such as
risperidone, a non-selective serotonin 2A (5-HT2A) receptor
antagonist [51].
Despite its broad clinical relevance, the preponderance of
evidence on how serotonin impacts behavioural adaptation
comes from studies of non-human animals [7, 52–56], whilst the
role of serotonin in human threat and safety learning has received
surprisingly little attention [57]. The experimental animal literature
has focused on instrumental reversal learning, whereby a learned
optimal behaviour (usually for obtaining food reward) becomes
disadvantageous and another behavioural strategy needs to be
adopted. Failure to adapt to new contingences is referred to as
perseveration. A major advantage of this experimental approach is
that similar paradigms, typically involving two choices, can be
used across species. In rats, impairing serotonin function via
neurotoxic depletion, chronic intermittent cold stress, or acute low
dose SSRI (1 mg/kg citalopram) disrupted reversal learning
[52, 56]. Enhancing serotonin function in rats via SSRI given
acutely at higher doses (5 or 10 mg/kg citalopram), or adminis-
tered repeatedly, enhanced reversal learning [52, 56]. There is
robust evidence that intact serotonin function in the OFC is critical
for reversal learning. Highly perseverative rats during reversal
learning had reduced levels of 5-HT2A receptors and the serotonin
metabolite 5-hydroxyindoleacetic acid (5-HIAA) in the OFC, and
decreased expression of monoamine oxidase and tryptophan
hydroxylase genes in the dorsal raphé nucleus (DRN) [53]. In
marmoset monkeys, targeted neurotoxic serotonin depletion of
the OFC via 5,7-dihydroxytryptamine (5,7-DHT), but not of the
caudate nucleus, has consistently produced reversal deficits
[54, 55, 58]. Depleting OFC serotonin has been proposed to
promote stimulus-response associations over stimulus-response-
reward goal-directed action [4, 59].
Whilst the effects of serotonin on Pavlovian threat reversal
learning have not been studied in any species, to our knowledge,
there is a body of work (mostly from non humans) indicating that
serotonin influences threat conditioning processes [57], more
commonly known as fear conditioning [60]. That Pavlovian threat
conditioning can also be studied across species represents a major
advantage. The directionality of effects is complex and can differ
by serotonergic manipulation, experimental paradigm, dependent
measure, stimulus, species, predictability, 5-HT receptor subtype,
and brain region [57, 61–66]. That serotonin can have opposing
effects to threats, however, is at the heart of an influential
theoretical framework for understanding serotonin function [67].
Serotonin signalling is postulated to restrain physiological
responses to proximal and innate threats (and thus inhibit panic),
whilst promoting anticipatory anxiety for distal, learned threats
[67]. Indeed, administration of the serotonin 2A/2C (5-HT2A, 5-
HT2C) receptor antagonist ritanserin to healthy humans enhanced
innate anxiety during simulated public speaking [68] yet reduced
learned anticipatory anxiety during Pavlovian conditioning [69].
Consistent with this framework, serotonin depletion attenuated
Pavlovian threat conditioning to inherently neutral cues and
corresponding amygdala activity in healthy humans [70]. There
are distinctions between circuits that respond to learned threats
(e.g. neutral cues), predators (e.g. snakes or spiders), and
aggressive conspecifics [71]. Serotonergic circuits can be engaged
differentially by innate versus learned threats [72] and by the
intensity of threat [73]. Secondary to our investigation of cognitive
flexibility, we also addressed whether depleting serotonin would
potentiate initial Pavlovian conditioning when employing innately
threatening conditioned stimuli.
Here, we conducted two independent experiments employing
acute tryptophan depletion (ATD) to determine the influence of
serotonin on Pavlovian and instrumental reversal learning in
healthy human volunteers. Depleting tryptophan, serotonin’s
biosynthetic precursor, decreases serotonin synthesis and function
[74–78]. Experiment 1 tested instrumental reversal learning.
Individuals acquired an adaptive behaviour through trial and
error learning, and the correct response subsequently changed
multiple times, necessitating cessation of the previous action and
performing a new behaviour. Experiment 2 examined reversal
learning in the Pavlovian domain [11, 79]. In a Pavlovian threat
conditioning procedure, participants were presented with two
cues (threatening faces, i.e. signs of aggressive conspecifics), one
of which was sometimes paired with an electric shock, while the
other was not. A reversal phase followed, whereby the originally
conditioned face became safe, and the initially safe face was
newly paired with shock (Supplementary Fig. 1) [79]. To assess
associative learning during Pavlovian conditioning and reversal,
the skin conductance response (SCR) was used as a measure of
(mostly sympathetic) autonomic nervous system responses
[13, 79–83].
Impairments in human instrumental reversal learning following
ATD have been difficult to detect to date [84–89]. Behaviour in
previous studies, however, was not reinforced with motivationally
salient feedback, which was instead more symbolic (e.g.
‘CORRECT’/‘WRONG’; ‘You win/lose 100 points’; higher or lower
pitched tone). Consequently, there may not have been sufficient
incentive to update or restrain action: any requirement for
serotonin signalling to perform the task at hand may have been
minimal enough to be unaffected by ATD [90]. Indeed, the
depletion achieved by ATD is relatively mild in comparison with
the profound depletion that is possible in experimental animals
[52, 54, 55]. Given the importance of serotonin in processing both
aversive [5, 91–93] and rewarding [1, 3, 7, 9] outcomes, we used an
innovative task (Fig. 1) incorporating feedback that was markedly
more salient than was used in previous reversal tasks [84–89].
Unlike previous human instrumental reversal learning tasks, the
present paradigm allowed for the influence of serotonin on
Fig. 1 Experiment 1 task schematic. TOP: The three rectangles with
coloured frames represent three example trials presented in the
acquisition phase. Purple ovals symbolise the button boxes.
Question marks signify the need to learn the correct hand-colour
association by trial and error. Downward pointing arrows indicate
the correct hand and button response for that trial. BOTTOM:
Curved arrows signify the reversal of colour-hand contingencies,
which occurred three times.















reward and punishment to be parsed. In this way, the reward
condition in our paradigm paralleled the non-human animal
studies whilst the punishment conditions extend the existing
literature. ATD has produced different effects on goal-directed
behaviour in healthy volunteers responding to obtain rewards
versus avoid punishments [94], and therefore we predicted that
effects of serotonin in the present experiment would depend on
valence.
Prior studies that did not find a perseverative deficit following
ATD employed largely probabilistic feedback [84–86] and a single
reversal [85, 86]. Other ATD studies were used primarily to test
observational reversal learning, where outcomes were not
contingent on responses [95, 96], or higher order cognitive
flexibility in the form of attentional set-shifting [87–89]. Similarly,
genetic variation in the serotonin transporter was not associated
with perseveration—our primary interest—but was related to
inappropriate behavioural shifting after losses during probabilistic
reversal [97]. Meanwhile, evidence of a perseverative deficit
following neurotoxic serotonin depletion of the marmoset OFC,
comes from a paradigm more similar to that employed in the
present study [54]: serial reversals on a deterministic schedule (in
the appetitive domain) were used, and a reversal deficit that
emerged only beginning in the second reversal was found. We
were therefore particularly interested in whether focusing on a
later reversal phase may be key to uncovering perseveration
following ATD in humans.
The aim of this study, therefore, was to address the following
questions. In Experiment 1: Does ATD induce perseveration in
instrumental reversal learning? Are deficits valence-dependent
[94]? Do these effects emerge in a later reversal phase, and
particularly when feedback is most salient? In Experiment 2: Does
ATD impair Pavlovian reversal learning? And does ATD have a
different effect on conditioning to threatening cues compared to
neutral cues? In the instrumental domain, we hypothesised that
ATD would lessen the impact of motivationally salient feedback to
guide behaviour, resulting in a perseverative deficit. More
specifically, we predicted that ATD would not impair reversal
learning in the neutral feedback condition, but that serotonin
would have a differential effect depending on salient rewarding
and/or punishing feedback. In the Pavlovian domain, we predicted
initial conditioning to innately threatening stimuli would be
potentiated by ATD and that autonomic responses would not
adapt flexibly to new contingencies following reversal. Instru-
mental and Pavlovian reversal learning deficits following serotonin
depletion would collectively point to a requirement of serotonin
for integrating new information about reinforcement contingen-
cies, which is fundamental to daily life and well-being.
MATERIALS AND METHODS
Acute tryptophan depletion
Healthy volunteers were assigned to receive ATD or placebo, in a
randomised, double-blind, between-groups design. The ATD group
consumed a drink containing the essential amino acids less tryptophan,
whereas the placebo drink was identical other than it included tryptophan
(see Supplementary Information for details). Blood samples were taken to
verify depletion.
EXPERIMENT 1
Participants. Sixty-nine healthy participants (mean age 24.28, 36 males)
completed the deterministic reversal learning task and were included in
the final analysis. One male participant in the depletion group was
excluded because he admitted to responding randomly later in the task.
Participants were screened to be medically healthy and free from any
psychiatric conditions, determined by the Mini International Neuropsy-
chiatric Interview [98]. Individuals who reported having a first-degree
relative (parent or sibling) with a psychiatric disorder were excluded upon
screening as well (see Supplementary Information for further screening
criteria). Volunteers provided informed consent before the study and were
paid for their participation. Groups did not differ in age, years of education,
trait impulsivity, or in baseline depressive and obsessive-compulsive
symptoms, shown in Supplementary Table 1.
General procedure. The protocol was approved by the Cambridge Central
NHS Research Ethics Committee (Reference # 16/EE/0101). The study took
place at the National Institute for Health Research/Wellcome Trust Clinical
Research Facility at Addenbrooke’s Hospital in Cambridge, England.
Participants arrived in the morning having fasted for at least 9 h prior,
gave a blood sample, and ingested either the placebo or ATD drink. To
assess mood and other feelings including alertness, we used a 16-item
visual analogue scale (VAS) at the beginning, middle, and end of the day-
long testing session. In the afternoon participants completed the
deterministic reversal learning task, along with several other tasks reported
elsewhere [65, 99, 100].
Instrumental reversal learning task. The task used in Experiment 1,
developed by Apergis-Schoute [101], is depicted in Fig. 1. As an incentive,
participants were told that depending on how well they performed the
task, they could win a bonus on their compensation for taking part in the
study. In reality, everyone received a small bonus. The instrumental
reversal paradigm was designed to increase task demands and thus
difficulty in comparison with previous reversal tasks [84–89], by including
serial reversals, salient feedback, and necessitating specific hand and finger
response mappings to stimuli. It had three reversals and a deterministic
schedule. Responses were entered via one of two ‘button boxes’ with
either the left or right hand, see Fig. 1. On each trial, the computer screen
was framed by a specific colour and displayed five boxes corresponding to
five buttons on each button box, one button per finger. The colour
indicated the correct hand to respond with, and a black dot inside one of
the five boxes on the screen indicated which finger to respond with,
depicted in Fig. 1. Participants were told they needed to learn the colour-
hand association by trial and error and that the association would change
multiple times within a run. A correct response required responding both
with the correct finger and the correct hand. A run consisted of four blocks
of 20 trials each: an acquisition block where the initial contingency was
established followed by three reversal blocks. The reinforcement schedule
was deterministic: the correct option led to positive feedback on 100% of
trials, whilst the incorrect response led to negative feedback on 100% of
trials. Trial order was randomised. There were four runs in random order,
and each contained a unique pair of colours framing the screen which was
counterbalanced. All runs contained the same visual feedback cartoon
stimuli (Supplementary Fig. 2): a smiling face with ‘two thumbs up’ for
correct responses, a face showing disappointment and a ‘thumbs down’
when incorrect, and an analogue alarm clock with a frown if a response
was not entered within the allotted time. The salience and valence of
feedback across runs was varied using the presence or absence of
prominent auditory stimuli. The primary run of interest had the most
salient auditory feedback: responding correctly to one colour resulted in
reward in the form of a prominent ‘cha-ching’ (slot machine) sound, whilst
correct responses to the other colour prevented (avoided) the occurrence
of an aversive buzzer noise (reward-punishment run). There was also a
reward-neutral run where a correct response to one colour frame resulted
in the reward auditory feedback whereas responding correctly or
incorrectly to the other colour resulted only in visual (neutral) but no
auditory feedback. In the punishment-neutral run, incorrect responses to
one colour frame were punished with the buzzer noise whereas correct or
incorrect responses to the other colour resulted only in visual feedback
(neutral). Finally, the task contained a neutral-neutral condition where no
auditory feedback was provided and only visual feedback via cartoons was
presented.
The experiment began with three training phases, each of which
required making correct responses on at least 80% of trials to advance to
the next stage otherwise the phase would be repeated. The first was self-
paced and served to familiarise participants with responding using the
button boxes. In the first training phase only, ‘LEFT’ or ‘RIGHT’ was
displayed on each trial to instruct the correct hand to use. There was a time
limit in the second (short) and third (longer) training phases and
participants were told to respond as quickly and accurately as possible.
The time window to make responses during the actual experiment was
automatically calibrated to each person based on their reaction times
during the final practice phase. The task was programmed in E-Prime 2.0
Professional. The primary dependent measure was trials to criterion, as
used in serotonin depletion studies in marmoset monkeys [54, 55], which
J.W. Kanen et al.
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we aimed to translate to humans here. The criterion was defined as making
four consecutive correct responses.
EXPERIMENT 2
Participants. Thirty healthy volunteers (mean age 25.44, 17 females)
completed the Pavlovian threat reversal task. Of these, two (1 female) were
deemed ‘non-responders’ for an undetectable SCR and were thus excluded
based on the following criteria: having SCR recordings with a magnitude of
less than 0.05 microsiemens (μS) on fewer than half of the CS+ trials
during the acquisition phase. Most studies define ‘non-responders’ based
on CS responses; however, see [102] for a discussion. All participants
provided written informed consent and were financially compensated. The
study was approved by the Cambridgeshire 2 Research Ethics Committee
(Reference # 09/H0308/51). Participants were eligible if they did not have a
personal or family history of major depressive disorder, bipolar disorder, or
any other psychiatric illness. Groups did not differ in age, years of
education, trait impulsivity, or in baseline depressive symptoms, shown in
Supplementary Table 2.
General procedure. Participants were assigned to receive either placebo
or the tryptophan-depleting drink in a randomised, double-blind design
(16 received depletion). Blood samples were collected at baseline and
before the task to verify tryptophan depletion. Participants completed
questionnaires including one assessing self-reported mood state. Data
were collected inside of a functional magnetic resonance imaging (fMRI)
scanner, but the fMRI data are not reported here. Participants returned for
a second session, where they received the other drink condition and also
completed different computerised tasks, results of which have been
published elsewhere [103, 104]. It is important that participants are naïve
to conditioning paradigms, and therefore the data reported here were
acquired in the first of two testing sessions spaced at least 1 week apart.
Conditioning procedure. The task [11] is depicted in Supplementary Fig. 1
and had two phases: acquisition and reversal. Two faces (face A and B) were
presented in each phase, for 4 s each with an inter-trial interval of 12 s [79].
The face images were selected from the Ekman series [105]. Participants
chose a shock level that they felt was uncomfortable but not painful. In the
acquisition phase, face A was presented 16 times without a shock
(conditioned stimulus plus; CS+) and coterminated with a 200ms shock
(unconditioned stimulus; US) on an additional eight trials (CS+US) that
were spread throughout the acquisition phase, while face B was presented
16 times and never paired with shock (CS−). In the reversal phase the faces
were presented again only the contingencies swapped: face A was
presented for 16 trials and was no longer paired with a shock (new CS−),
while face B was newly paired with a shock on 8 trials amidst an additional
16 unreinforced trials (new CS+). Trials were pseudorandomised and
designation of face A and B was counterbalanced. Reversal was unsignaled
and immediately followed acquisition without a break. SCR was the
dependent measure. The primary focus was the SCR to unreinforced trials, to
avoid contamination by the shock itself. SCRs were defined as the base-to-
peak difference during a 7 s interval beginning 0.5 s after stimulus onset.
SCRs were normalised for each individual participant by dividing values from
each trial by the peak amplitude.
Multiple comparisons. Correction for multiple comparisons where rele-
vant, was conducted using the Benjamini-Hochberg procedure [106]. The





Omnibus analysis: Instrumental reversal learning was impaired
following ATD, and the core deficits are displayed in Fig. 2. First,
omnibus repeated measures analysis of variance (ANOVA) was
performed across all valence conditions and blocks. In the most
salient condition participants had to make separate responses to
obtain reward and avoid punishment (reward-punishment; see
Methods). The other conditions incorporated either only neutral
feedback (neutral-neutral), or neutral feedback with reward
(reward-neutral) or punishment (punishment-neutral). The depen-
dent measure for all analyses was trials to criterion (see Methods).
Reaction time data are presented in the Supplementary Informa-
tion. The omnibus ANOVA, with serotonin status (placebo,
depletion) as a between-subjects factor, valence (reward-punish-
ment, reward-neutral, punishment-neutral, neutral-neutral) and
block (acquisition, reversal 1, reversal 2, reversal 3) as within-
subjects factors, revealed a significant serotonin × valence × block
interaction (F(9,603)= 2.024, p= 0.035, ηp
2= 0.029). There was no
main effect of serotonin status (F(1,67)= 1.869, p= 0.176, ηp
2=
0.027).
Acquisition learning: Next we verified that this effect was not
driven by acquisition learning. Indeed, ATD had no effect on initial
discrimination learning in the reward-punishment condition
(t(67)= 1.115, p= 0.269, d= 0.268), reward-neutral (t(67)=−0.325,
p= 0.746, d=−0.078), punishment-neutral (t(67)=−0.688,
Fig. 2 Instrumental reversal learning performance by block. More trials to criterion signifies worse performance. Asterisks represent
significance at p < 0.05. Error bars represent ±1 standard error of the mean. a Impairment in Reversal 2 of the reward-punishment condition
(R-P). b Impairments in Reversals 1 and 2 of the reward-neutral condition (R-N). c No differences in instrumental performance in the
punishment-neutral condition (P–N). d No differences in instrumental performance in the neutral-neutral condition (N–N).
J.W. Kanen et al.
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p= 0.494, d=−0.166) or neutral-neutral conditions (t(64)= 0.891,
p= 0.376, d= 0.214), shown in Fig. 2.
Reversal blocks: Results are shown in Fig. 2. To assess the nature
of the reversal learning deficit, the significant three-way interaction
was followed up with t tests in a sequence guided by two key a
priori hypotheses. First, serotonin signalling is particularly engaged
when responding to motivationally salient feedback [90], and
therefore a reversal learning deficit should be most likely in the
highest salience condition (reward-punishment). Second, serotonin
depletion in the marmoset monkey OFC has been shown to induce
the most pronounced instrumental reversal learning deficit in the
second reversal block, without impacting the initial reversal [54].
The first follow-up test of reversal learning, therefore, assessed the
second reversal of the most salient condition (reward-punishment)
and indeed revealed a deficit: participants under ATD required
more trials to criterion than on placebo (t(59)= 2.281, p= 0.026,
d= 0.546). We then tested whether the effect in the second
reversal was present in the other, less salient, conditions. There was
a significant deficit under ATD in the reward-neutral condition (t(61)
= 2.413, p= 0.019, d= 0.578), and not in the punishment-neutral
(t(67)=−0.512, p= 0.61, d=−0.123) or neutral-neutral (t(67)=
0.572, p= 0.569, d= 0.138) conditions. Next we tested whether a
deficit was present in the first reversal. Individuals under depletion
required more trials to criterion in the reward-neutral condition
(t(67)= 2.113, p= 0.038, d= 0.509), but not in the reward-
punishment (t(67)=−0.528, p= 0.599, d=−0.127), punishment-
neutral (t(67)= 1.439, p= 0.155, d= 0.346), or neutral-neutral (t(64)
= 1.051, p= 0.297, d= 0.252) conditions. Finally, we assessed
whether there was any deficit in the last reversal block.
Performance was not impaired in the final reversal phase in the
reward-punishment (t(67)= 1.097, p= 0.277, d= 0.264), reward-
neutral (t(67)=−0.124, p= 0.902, d=−0.030), punishment-neutral
(t(67)= 1.348, p= 0.182, d= 0.325), or neutral-neutral (t(67)=
−0.526, p= 0.601, d=−0.127) conditions. The key deficits, from
the reward-punishment and reward-neutral conditions identified in
the second reversal block, additionally survived the Benjamini-
Hochberg procedure (see Methods), for 12 comparisons (four
valence conditions and three reversals), and were therefore the
primary drivers of the serotonin × valence × block interaction.
Relationship between instrumental reversal deficits and extent of
depletion. More pronounced depletion was significantly corre-
lated with the key reversal deficits, shown in Fig. 3. To further
substantiate the deficits observed upon depletion, correlation
analyses between behaviour and individual subject plasma
samples were conducted. First, this was performed for behaviour
in the second reversal block during both the reward-punishment
and reward-neutral conditions, where significant deficits were
found at the group level. Indeed, greater extent of depletion was
significantly correlated with the magnitude of these key reversal
impairments: more pronounced depletion was related to worse
performance in both the reward-punishment condition (r(66)=
−0.266, p= 0.031) and the reward-neutral condition (r(66)=−0.25,
p= 0.043). These results are displayed in Fig. 3a, b, respectively.
The other observed behavioural impairment, from the first reversal
in the reward-neutral condition, was also significantly correlated
with the extent of depletion (r(66)=−0.311, p= 0.011).
Fig. 3 Relationship between extent of depletion and instrumental
reversal learning performance. a Reward-punishment (R-P) condi-
tion. b Reward-neutral (R-N) condition. Both correlations were
significant. ΔTRP:LNAA is the change in the ratio of tryptophan to
large neutral amino acids; 0 indicates no change. A greater decrease
(post-depletion minus pre-depletion blood plasma results) in the
TRP:LNAA ratio indicates a more extensive depletion (more negative
y-axis values). Reversal learning is indexed here as the number of
trials to criterion in the second reversal block. Increasing x-axis
values represent more trials to criterion and thus worse reversal
performance. Shading indicates ±1 standard error (SE).
Fig. 4 Pavlovian acquisition and reversal SCR data (Experiment 2), visualised in two different ways. Error bars represent ±1 standard error
(SE). a Difference scores of CS+ minus CS−, indicative of the extent of discrimination learning to the two stimuli. Asterisks (*) indicate
significance at p < 0.05; double asterisks (**) denote significance at p < 0.01. b All stimuli displayed separately. CSpACQ= (initial) CS+ during
acquisition; CSmACQ= (initial) CS− during acquisition; CSpREV= (new) CS+ during reversal; CSmREV= (new) CS– during reversal.
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Blood analysis and mood. Robust tryptophan depletion was
achieved, as verified by plasma samples (t(64)=−18.725, p=
1.161 × 10−27, d=−4.610) using the ΔTRP:LNAA (change, from
baseline to approximately 4.5 h after drink administration [110], in
the ratio of tryptophan to large neutral amino acids [75] (see
Supplementary Information). The mean ΔTRP:LNAA was
−0.000023 (standard error of the mean, SEM= 0.004480) in the
placebo group and −0.100244 (SEM= 0.002928) in the depletion
group. Plasma levels were unavailable for three participants: one
due to an error in the centrifugation and freezing procedure,
and two due to difficulty with venepuncture. Self-reported mood
assessed using a VAS, available for 63 participants, was unaffected
by ATD (p > 0.05).
EXPERIMENT 2
Omnibus analysis. SCR data are displayed in Fig. 4a, b. First, we
performed an omnibus analysis to determine whether SCR to the
two stimuli across both phases was affected by ATD. Repeated
measures ANOVA, with serotonin status (placebo, depletion) as a
between-subjects factor and phase (acquisition, reversal) and
stimulus (CS+, CS−) as within-subjects factors revealed a
significant three-way serotonin × phase × stimulus interaction
(F(1,26)= 17.604, p= 0.00028, ηp
2= 0.404). Additionally, there were
significant two-way interactions between phase × stimulus
(F(1,26)= 47.225, p= 2.7 × 10
−7, ηp
2= 0.645) and serotonin × phase
(F(1,26)= 11.258, p= 0.002, ηp
2= 0.302). There was a main effect of
stimulus (F(1,26)= 73.410, p= 4.77 × 10
−9, ηp
2= 0.738), no main
effect of phase (F(1,26)= 3.756, p= 0.064, ηp
2= 0.126), and no
serotonin × stimulus interaction (F(1,26)= 0.0001, p= 0.992, ηp
2=
4 × 10−6). There was no main effect of serotonin status (F(1,26)=
0.374, p= 0.546, ηp
2= 0.014). Pavlovian reversal deficits were
confirmed in an additional ANOVA. Two delta scores were
calculated [111]: new CS− minus old CS+, and new CS+ minus
old CS−. The two delta scores were entered into the ANOVA as a
two-level within-subject factor, and the between-subjects factor
was serotonin status (placebo, depletion). This revealed a main
effect of serotonin status (F(1,26)= 11.258, p= 0.002, ηp
2= 0.302),
an effect of stimulus (F(1,26)= 73.410, p= 4.77 × 10
−9, ηp
2= 0.738),
and no serotonin × stimulus interaction (F(1,26)= 1.03 × 10
−4, p=
0.992, ηp
2= 4 × 10−6).
Acquisition of conditioning. Conditioning data are displayed in
Fig. 4a, b. Differential conditioning (CS+ versus CS−) was attained
in both the placebo and ATD groups (follow-up paired t tests: t(11)
= 6.866, p= 0.000027, d= 1.982, for placebo; t(15)= 7.181, p=
0.000003, d= 1.795, for depletion). Conditioning was significantly
stronger following depletion compared to the placebo group: we
calculated a difference score of CS+ minus CS− for each group,
and the magnitude of the CS+ relative to the CS− was
significantly greater in the ATD group (t(26)=−2.245, p= 0.034,
d=−0.857).
Reversal of conditioning. The reversal learning results are
depicted in Fig. 4a, b. During the reversal phase, follow-up t tests
indicated the placebo group successfully conditioned to the new
CS+ (t(11)= 3.684, p= 0.004, d= 1.064). The depletion group,
however, did not show discrimination between the new CS+ and
the new CS− (t(15)=−1.031, p= 0.319, d=−0.258), indicating a
reversal learning impairment. Comparing the difference score
during the reversal phase (new CS+ minus new CS−) between
placebo and ATD also confirmed reversal learning was impaired
(t(26)= 3.880, p= 0.001, d= 1.482).
Changes in physiological responses to stimuli across phase: old
versus new. Follow-up paired t tests showed that responding to
the initial CS+ extinguished upon reversal both within
the placebo group (initial CS+ versus new CS−; t(11)= 2.799,
p= 0.017, d= 0.808) and under ATD (t(15)= 6.402, p= 0.000012,
d= 1.6). SCR to the initial CS− increased upon reversal in the
placebo group (t(11)=−4.172, p= 0.002, d=−1.204) but critically,
there was no difference in SCR to the initial CS− in acquisition
compared to the new CS+ (old CS−) in reversal after ATD (t(15)=
−1.370, p= 0.191, d=−0.342). The reversal impairment following
ATD was driven by a failure to assign new aversive value, whereas
safety learning upon reversal was intact.
Correlations between Pavlovian measures and extent of depletion.
Next we tested whether the extent of depletion, as assessed via
plasma samples, was related to our measures of Pavlovian threat
conditioning and reversal. Extent of depletion was not correlated
with the magnitude of the SCR difference score in the acquisition
phase (r(27)= 0.210, p= 0.294); however, there was a highly
significant correlation between greater depletion and a more
pronounced reversal learning deficit (r(27)=−0.536, p= 0.004),
depicted in Fig. 5. The Pavlovian reversal learning deficit was
indexed by SCR to the CS+ minus the CS− in the reversal phase.
Unconditioned responses. Unconditioned responses [URs] (SCR to
the shock itself) were unaffected by ATD. The peak UR for each
subject was extracted from each phase (acquisition and reversal).
Repeated measures ANOVA with serotonin status (placebo,
depletion) as a between-subjects factor and phase (acquisition,
reversal) as a within-subjects factor revealed no main effect of
serotonin status on URs (F(1,26)= 0.015, p= 0.904, ηp
2= 0.001) and
no serotonin × phase interaction (F(1,26)= 1.137, p= 0.296, ηp
2=
0.042). There was a significant effect of phase (F(1,26)= 9.311, p=
0.005, ηp
2= 0.264), such that URs were lower during the reversal
phase than in the acquisition phase. The extent of depletion was
not correlated with URs during acquisition (r(27)= 0.04, p= 0.843)
or reversal (r(27)=−0.14, p= 0.485).
Blood analysis and mood. Robust depletion was also achieved in
Experiment 2 (t(17)=−4.907, p= 0.000132, d=−2.008). The mean
ΔTRP:LNAA was 0.009225 (SEM= 0.025939) in the placebo group
and 0.153429 (SEM= 0.013812) in the depletion group. Blood
results from one participant were unavailable. Mood, assessed
with the positive and negative affect schedule [112] after
depletion had taken effect, was unaffected: there was no
difference between serotonin status for positive (p > 0.05) or
negative affect (p > 0.05).
Fig. 5 Experiment 2. Relationship between extent of depletion and
degree of Pavlovian reversal learning impairment. The correla-
tion was significant. ΔTRP:LNAA is the change in the ratio of
tryptophan to large neutral amino acids; y= 0 indicates no change.
A greater change (post-depletion blood minus pre-depletion results)
in the TRP:LNAA ratio indicates a more extensive depletion (more
negative y-axis values). Reversal learning is indexed here as the
difference score between CS+ and CS− in the reversal phase.
Increasing x-axis values represent better discrimination learning
assessed by SCR between the CS+ and CS− in the reversal phase
(i.e. better reversal learning). Shading indicates ±1 standard
error (SE).




We have provided convergent evidence from two independent
experiments that serotonin depletion effected by acute dietary
tryptophan depletion impairs human reversal learning in both the
instrumental and Pavlovian domains (Experiments 1 and 2,
respectively). The magnitude of the instrumental and Pavlovian
reversal deficits, moreover, were both correlated with the extent
of depletion assessed by plasma samples. Both the human
instrumental and Pavlovian results are further strengthened by
their consistency with studies of experimental animals following
neurotoxic serotonin depletion [52, 54–56]. Remarkably, in rats,
marmosets, and humans, the effect of serotonin depletion in the
instrumental domain emerged most consistently upon the second
reversal of contingencies [52, 54, 55]. Pavlovian extinction,
meanwhile, was intact following serotonin depletion in humans,
which is also consistent with data from marmosets following OFC
serotonin depletion: (instrumental) extinction was unimpaired
[113]. At the same time, initial Pavlovian conditioning to innately
threatening cues was enhanced under serotonin depletion. Mood
was unaffected, in line with the ATD literature in healthy humans
[75, 114, 115].
Perseverative deficits in human instrumental reversal learning
following ATD have not been easily captured to date [84–86],
possibly owing in part to ATD inducing a transient and relatively
mild depletion in comparison [116] with the profound depletion
that is possible in experimental animals using 5,7-DHT
[52, 54, 55, 113]. These ATD studies employed largely probabilistic
feedback [84–86], with a single reversal [85, 86], and non-salient
feedback [84–86]. The innovative instrumental task used here was
unique in that it incorporated highly salient feedback, multiple
reversals on a deterministic schedule, and increased cognitive
load. The deterministic schedule with multiple reversals, in
particular, aligns with the design of marmoset studies that have
provided quintessential evidence that OFC serotonin depletion
induces perseveration [54, 55].
Whilst the instrumental deficits on both the most salient
(reward and punishment) and reward-only, but not punishment-
only condition, as reported here, may at first seem surprising
given the well-established role of serotonin in aversive processing
[4, 5], this indeed aligns with the literature across species: the key
marmoset studies on serotonin depletion and perseveration were
conducted in the appetitive domain [54, 55, 113], and human ATD
affected the appetitive but not aversive domain in a 4-choice
probabilistic task on which computational modelling also revealed
enhanced perseveration [9]. The depletion group here, none-
theless, performed worse numerically in reversals 1 and 3 (Fig. 2c)
during the punishment-only condition.
There are several possible explanations for the instrumental
reversal deficits observed following ATD. A marmoset study,
employing reinforcement that most closely resembles the reward-
neutral condition in the present study, and designed to
interrogate the nature of the deficit that emerged upon the
second reversal of contingencies [54], indicated that the reversal
impairment following 5,7-DHT in OFC was due to an inability to
disengage from the previously rewarded stimulus, rather than a
failure to re-engage with the previously incorrect stimulus (learned
avoidance) or reduced proactive interference [55]. When the
subject arrives at the second reversal, two sets of competing
associations have been experienced previously—the original and
the reversed contingencies. While less likely applicable to the
reward-neutral data, it remains possible that the deficit observed
in the reward-punishment condition—a reinforcement structure
not examined in marmosets [54, 55]—is related to an attenuation
of proactive interference following ATD that ordinarily (under
placebo conditions) biases responding towards the original
association. While it is unclear why deficits were not observed in
the third reversal, it is possible the aforementioned underpinning
effects were short-lived.
The Pavlovian reversal findings reported here resemble those
reported in OCD [11] and healthy humans under stress [117], and
align with other studies of serotonin in rats, monkeys, and humans
[56, 69, 113]. The Pavlovian reversal deficit in OCD, indexed by SCR
on an identical paradigm, was explained by dysfunctional activity
in the ventromedial prefrontal cortex (vmPFC), which receives rich
serotonergic innervation [118]. Likewise, using SCR and a similar
design to that used here (but with neutral cues), upon reversal,
stress also attenuated the acquisition of threat responses to the
newly threatening (previously safe) stimulus, while leaving
extinction learning to the previously threatening cue intact
[117]. The Pavlovian reversal deficits after serotonin depletion, in
the present study, and after stress [117], are furthermore
consistent with the finding that under 5-HT2A/C receptor block-
ade, a CS− (presented during habituation) failed to acquire
aversive value during subsequent threat conditioning [69]. These
parallels are striking, and are consonant with data from rats: stress,
and separately serotonin depletion, produced comparable deficits
in (instrumental) reversal learning [56]. Serotonin release in rats
during behavioural testing, moreover, was reduced by stress, and
an SSRI given acutely ameliorated the detrimental effect of stress
on reversal learning [56]. The deleterious effects of serotonin
depletion and stress on reversal learning can be interpreted as a
selective impairment in integrating new information about a
change in reinforcement contingencies, needed to update the
representation of aversive value appropriately [117].
There are a number of theoretical and empirical considerations
that can help link the instrumental and Pavlovian results. Whilst
we do not know the neural locus of the present reversal
impairments following ATD, work in the instrumental domain
from experimental animals [54, 55, 113] and individuals with OCD
[12, 119] enables us to highlight the OFC. The Pavlovian reversal
data from OCD, at the same time, point to the vmPFC [11]. Indeed,
damage subsuming the human OFC and vmPFC (which may
include medial OFC structures such as area 14) impairs flexible
stimulus-outcome learning and value-guided choice consistency,
which may reflect disrupted integration of values on the basis of
recalled outcomes [120]. Rhesus monkeys with lesions to the
anterior cingulate cortex (ACC), meanwhile, showed impaired
reversal of both action-outcome and stimulus-outcome contin-
gencies [121]. Furthermore, there is evidence that ATD reduces
Pavlovian influences over instrumental action in healthy humans,
including in a Pavlovian-to-instrumental transfer (PIT) test, albeit
selectively under conditions of punishment [92, 93]. Depleting
OFC serotonin has been proposed to remove descending
inhibitory mechanisms that ordinarily bias away from aversive
processing (engaging with negative stimuli or outcomes),
which would also account for the promotion of stimulus-
response associations over stimulus-response-reward goal-
directed action [4, 59].
To inform how serotonin might be engaged (i.e. released or
inhibited) as reversal learning ensues, the following study in mice
is informative. DRN 5-HT neuron activation tracked both positive
and negative prediction errors during reversal learning [7]. These
signals were qualitatively similar to dopaminergic prediction error
signalling but differed in their time course: dopaminergic
responses to cues were more quickly established and withdrawn.
The authors posited it would follow that as cues result in more
positive outcomes, dopaminergic signalling would be favoured
temporarily thus invigorating behaviour, and when more negative
outcomes emerge (during reversal, for instance) serotonergic
signalling would be favoured instead, consequently promoting
behavioural inhibition [7]. The contribution of dopaminergic
versus serotonergic signalling would differ across valence condi-
tions, and this framework, derived from an instrumental paradigm,
can be extended to Pavlovian reversal as well.
Consideration of the influence of serotonin on specific
amygdala sub-nuclei in rodents may also inform our human
J.W. Kanen et al.
7
Molecular Psychiatry
conditioning findings. The central nucleus of the amygdala (CeA)
is the major source of output from the amygdala and its
downstream projections ultimately produce defence responses
such as perspiration in humans and freezing in rodents [122].
Critically, cells expressing 5-HT2A receptors in the CeA are
differentially engaged by innate versus learned threats [72].
Inhibition of these 5-HT2A-expressing cells upregulates innate
threat responses in mice and downregulates learned threat
responses [72]. This is remarkably congruent with our observation
that reducing serotonin function potentiated conditioning to
innate threats, on the one hand, and findings from previous
studies that reduction of serotonin signalling attenuates threat
conditioning to learned (neutral) cues [69, 70]. The implication is
that threat (here faces) normally releases 5-HT onto excitatory
5-HT2 receptors of the amygdala system that normally restrains
innate aversion and promotes conditioning. Thus, ATD disinhib-
ited innate responses (SCRs) to the face CS+, resulting in what
appeared to be greater initial conditioning but may actually reflect
larger autonomic responses that do not consolidate to form
an associative memory. These divergent results may inform
therapeutic, and possibly adverse, effects of serotonin modulating
drugs. Indeed, risperidone (amongst other things a 5-HT2 receptor
antagonist) exacerbated responses to innate threats and alleviated
threat responses to previously neutral cues [72]. Furthermore,
humans with selective damage to the basolateral amygdala (BLA),
with the CeA preserved, showed hypervigilant responses to fearful
faces (innate threat), which was interpreted as the removal of an
inhibitory influence of the BLA over the CeA [123]. Indeed, the BLA
receives particularly rich serotonergic innervation [57], which, in
conjunction with the role of serotonin in the CeA for innate threats
may be important for understanding our results.
Limitations
As in other human ATD studies we did not measure serotonin
directly, and instead used a widely accepted proxy measurement
[75]. Whilst some have criticised ATD as a technique for studying
serotonin in particular [124], the method has been robustly
defended [77, 125]. Critically, the present findings align with
deficits following profound neurotoxic serotonin depletion in both
rats [52] and marmoset monkeys [54, 55, 113]. Our results build
upon other studies, for instance on ‘waiting impulsivity’, that show
parallel behavioural effects between neurotoxic depletions in
experimental animals [126] and ATD in healthy humans [116], thus
further bolstering the validity of ATD for studying serotonin.
Other limitations include the sample size of Experiment 2, which
was relatively small. There were slight differences in Experiments 1
and 2 with respect to the inclusion criteria and general
procedures, including different amino acid mixtures (see Supple-
mentary Information), as they were conducted independently
from one another. Experiment 2, moreover, contained only one
reversal, whereas Experiment 1 incorporated multiple reversals;
however, as a result, habituation of SCR, which can often occur in
later phases of a threat conditioning experiment, may have been
avoided [65, 127].
Whilst we did not apply psychophysiological modelling to the
SCR data, which has the potential to increase effect sizes and has
gained traction as an analysis approach [80], we observed large
effect sizes nonetheless with base-to-peak scoring of SCR. The
method used here, furthermore, was best at distinguishing
different phases of an experiment [80], which is consistent with
our primary aim of determining whether ATD affected acquisition,
reversal, or both.
We did not apply computational modelling to the Pavlovian
data, which in future efforts could reveal how serotonin influences
associative learning dynamics in finer detail [13, 81, 117]. The
feedback structure of the instrumental task, furthermore, was not
conducive to standard reinforcement learning models, and could
be modified in future studies to this end.
ATD can affect early processing in the auditory cortex [128], and
our effects in Experiment 1 were seen in conditions of salient
auditory feedback. Whilst the contribution of serotonin in sensory
versus frontal areas (e.g. OFC) cannot be determined from the
present data, auditory processing was not required in Experiment
2, yet reversal impairments were observed. More generally, the
OFC is proposed to represent task states (e.g. given the current
state, is choice A or B best?) and the extent of involvement of
sensory areas is likely to depend on whether the state can be
inferred from perceptual information (observable) or unobserva-
ble information (e.g. from working memory) [129].
CONCLUSIONS
We provide evidence of human reversal learning impairments
following serotonin depletion, in both the instrumental and
Pavlovian domains, across two independent experiments. Deficits
in both domains were underscored by significant correlations
showing that a greater extent of depletion, as assessed by plasma
samples, was associated with more pronounced reversal impair-
ments. Strikingly, the results align with data from neurotoxic
serotonin depletion in experimental animals [52, 54, 55, 113],
stress induction in humans [117] and rats [56], and individuals
with OCD [11].
That serotonin depletion impaired these fundamental learning
processes pervasive in daily life highlights a failure mode that
could lead to significant distress and impairment. The reversal
deficits presented, furthermore, indicate how serotonergic dys-
function could impede the ability to engage in cognitive
behavioural therapies. The present results therefore advance
knowledge on the neurochemical basis of flexible Pavlovian and
instrumental learning, which has implications for the under-
standing and treatment of numerous clinical conditions
including OCD.
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